UMD researchers have discovered key mechanisms in gene regulation that could improve the design of RNA-based medicines.
Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback